Key takeaway:
The new University of Houston Cancer Immunotherapy Biomarker Core facility will accelerate biomarker discovery, improve immunotherapy targeting and expand research capacity across Texas — enhancing the state's competitiveness in cancer research and ultimately improving patient outcomes.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
